Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2020 / N 3

Небулайзерная терапия в эпоху пандемии COVID-19
О.Н. Бродская, А.С. Белевский, М.А. Макарова

References

1. Ministry of Healthcare of the Russian Federation. Prevention, diagnosis, and treatment of novel coronavirus infection (COVID-19): temporary guidelines. Version 10 (08.02.2021). Moscow, 2021. 260 p. (In Russian).
2. COVID-19 coronavirus pandemic. Last update 2021 Mar 22. Worldometer. Available from: https://www.worldometers.info/coronavirus/ Accessed 2021 Mar 22.
3. Brodskaya ON. Nebulizer therapy for obstructive pulmonary diseases: yesterday, today, and tomorrow. Asthma and Allergy 2019;3:22-8 (In Russian).
4. Global Initiative for Chronic Obstructive Lung Diseases. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung diseases. 2020 report. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf Accessed 2021 Mar 22.
5. Global Initiative for Asthma. Global strategy for asthma management and prevention. Updated 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf Accessed 2021 Mar 22.
6. Sethi S, Barjaktarevic IZ, Tashkin DP. The use of nebulized pharmacotherapies during the COVID-19 pandemic. Therapeutic Advances in Respiratory Disease 2020 Jan-Dec;14:1753466620954366.
7. Liu Y, Ning Z, Chen Y, Guo M, Liu Y, Gali NK, Sun L, Duan Y, Cai J, Westerdahl D, Liu X, Xu K, Ho KF, Kan H, Fu Q, Lan K. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 2020 Jun;582(7813):557-60.
8. Cheng VCC, Wong SC, Chen JHK, Yip CCY, Chuang VWM, Tsang QTY, Sridhar S, Chan JFW, Ho PL, Yuen KY. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infection Control & Hospital Epidemiology 2020 May;41(5):493-8.
9. Faridi S, Niazi S, Sadeghi K, Naddafi K, Yavarian J, Shamsipour M, Jandaghi NZS, Sadeghniiat K, Nabizadeh R, Yunesian M, Momeniha F, Mokamel A, Hassanvand MS, Azad TM. A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran. The Science of the Total Environment 2020 Jul;725:138401.
10. World Health Organization. Overview. Transmission of SARS-CoV-2: implications for infection prevention precautions. Scientific brief. 9 July 2020. Available from: https://www.who.int/publications/i/item/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations Accessed 2021 Mar 22.
11. Heinzerling A, Stuckey MJ, Scheuer T, Xu K, Perkins KM, Resseger H, Magill S, Verani JR, Jain S, Acosta M, Epson E. Transmission of COVID-19 to health care personnel during exposures to a hospitalized patient – Solano County, California, February 2020. MMWR. Morbidity and Mortality Weekly Report 2020 Apr;69(15):472-6.
12. Jackson T, Deibert D, Wyatt G, Durand-Moreau Q, Adisesh A, Khunti K, Khunti S, Smith S, Chan XHS, Ross L, Roberts N, Toomey E, Greenhalgh T, Arora I, Black SM, Drake J, Syam N, Temple R, Straube S. Classification of aerosol-generating procedures: a rapid systematic review. BMJ Open Respiratory Research 2020 Oct;7(1):e000730.
13. World Health Organization. Overview. Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. Interim guidance. 29 June 2020. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC-2020.4 Accessed 2021 Mar 22.
14. Fink JB, Ehrmann S, Li J, Dailey P, McKiernan P, Darquenne C, Martin AR, Rothen-Rutishauser B, Kuehl PJ, Häussermann S, MacLoughlin R, Smaldone GC, Muellinger B, Corcoran TE, Dhand R. Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine. Journal of Aerosol Medicine and Pulmonary Drug Delivery 2020 Dec;33(6):300-4.
15. Edwards DA, Man JC, Brand P, Katwsta JP, Sommerer K, Stone HA, Nardell E, Scheuch G. Inhaling to mitigate exhaled bioaerosols. Proceedings of the National Academy of Sciences of the USA 2004 Dec;101(50):17383-8.
16. Global Initiative for Chronic Obstructive Lung Diseases.. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung diseases. 2021 report. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf Accessed 2020 Mar 22.
17. Global Initiative for Asthma. Interim guidance about COVID-19 and asthma. Updated 20 Dec 2020. GINA Global strategy for asthma management and prevention. Available from: https://ginasthma.org/wp-content/uploads/2020/12/GINA-interim-guidance-on-COVID-19-and-asthma-20_12_20.pdf Accessed 2021 Mar 22.
18. National Institute for Health and Care Excellence. COVID-19 rapid guideline: cystic fibrosis. NICE guideline [NG170]. Published date: 09 April 2020. Last updated: 07 October 2020. Available from: nice.org.uk/guidance/ng170 Accessed 2021 Mar 22.
19. Li C, Luo F, Liu C, Xiong N, Xu Z, Zhang W, Yang M, Wang Y, Liu D, Yu C, Zeng J, Zhang L, Li D, Liu Y, Feng M, Liu R, Mei J, Deng S, Zeng Z, He Y, Liu H, Shi Z, Duan M, Kang D, Liao J, Li W, Liu L. Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial. Annals in Medicine 2021 Dec;53(1):391-401.
20. Daxon BT, Lark E, Matzek LJ, Fields AR, Haselton KJ. Nebulized nitroglycerin for coronavirus disease 2019-associated acute respiratory distress syndrome: a case report. A & A Practice 2021 Feb;15(2):e01376.
21. van Haren FMP, Richardson A, Yoon HJ, Artigas A, Laffey JG, Dixon B, Smith R, Vilaseca AB, Barbera RA, Ismail TI, Mahrous RS, Badr M, De Nucci G, Sverdloff C, van Loon LM, Camprubi-Rimblas M, Cosgrave DW, Smoot TL, Staas S, Sann K, Sas C, Belani A, Hillman C, Shute J, Carroll M, Wilkinson T, Carroll M, Singh D, Page C. INHALEd nebulised unfractionated HEParin for the treatment of hospitalised patients with COVID-19 (INHALE-HEP): Protocol and statistical analysis plan for an investigator-initiated international metatrial of randomised studies. British Journal of Clinical Pharmacology 2020 Dec 29. doi: 10.1111/bcp.14714. Online ahead of print.
22. Mary A, Hénaut L, Macq PY, Badoux L, Cappe A, Porée T, Eckes M, Dupont H, Brazier M. Rationale for COVID-19 treatment by nebulized interferon-β-1b – literature review and personal preliminary experience. Frontiers in Pharmacology 2020 Nov;11:592543.
23. Dushianthan A, Clark H, Madsen J, Mogg R, Matthews L, Berry L, de la Serna JB, Batchelor J, Brealey D, Hussell T, Porter J, Djukanovic R, Feelisch M, Postle A, Grocott MPW. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): a structured summary of a study protocol for a randomized controlled trial. Trials 2020 Dec;21(1):1014.
24. Cazzola M, Ora J, Bianco A, Rogliani P, Matera MG. Guidance on nebulization during the current COVID-19 pandemic. Respiratory Medicine 2021 Jan;176:106236.
25. British Thoracic Society. COVID-19: information for the respiratory community. Last update 2021 Jan 28. Available from: https://www.brit-thoracic.org.uk/covid-19/covid-19-information-for-the-respiratory-community/ Accessed 2021 Mar 22.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]